Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment

Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment

Background Microsatellite instability (MSI) represents the first pan-cancer biomarker approved to guide immune checkpoint blockade (ICB) treatment. However its widespread testing, especially outside of gastrointestinal cancer, is hampered by tissue availability.Methods An algorithm for detecting MSI...

Full description

Bibliographic Details
Main Authors:	Lin Shen, Chan Gao, Yifan Zhou, Jing Gao, Xiaochen Zhao, Jifang Gong, Zhenghang Wang, Xicheng Wang, Zhongwu Li, Dalei Wang, Xiaofang Li, Yuezong Bai
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/8/2/e001297.full

Similar Items

The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
by: Qiao-Xuan Wang, et al.
Published: (2021-01-01)

PD-1 blockade as a future treatment for colorectal cancer with microsatellite instability
by: Diana Maria Leite da Cunha Russo, et al.
Published: (2020-10-01)

PD-1 blockade as a future treatment for colorectal cancer with microsatellite instability
by: Diana Maria Leite da Cunha Russo
Published: (2021)

Novel software tool for microsatellite instability classification and landscape of microsatellite instability in osteosarcoma
by: Wang, Chen
Published: (2019)

Predictive biomarkers for tumor immune checkpoint blockade
by: Tong M, et al.
Published: (2018-10-01)

Epigenetic checkpoint blockade: new booster for immunotherapy
by: Ziqiao Wang, et al.
Published: (2021-07-01)

PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer
by: Ding-Xin Liu, et al.
Published: (2020-01-01)

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
by: Romain Cohen, et al.
Published: (2021-03-01)

Rapid regression of microsatellite instability-high/programmed cell death ligand 1-negative recurrent endometrial carcinoma by immune checkpoint blockade with pembrolizumab: A case report and literature review
by: Akihiro Takeda, et al.
Published: (2020-05-01)

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy
by: Hongru Shen, et al.
Published: (2020-12-01)

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer
by: Jian Xiao, et al.
Published: (2021-03-01)

The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability- high Metastatic Colorectal Cancer
by: Jong Yoon Lee
Published: (2021-05-01)

Neutrophils in the era of immune checkpoint blockade
by: Solange Peters, et al.
Published: (2021-07-01)

Immune-Checkpoint Blockade Therapy in Lymphoma
by: Ayumi Kuzume, et al.
Published: (2020-07-01)

Acquired Resistance to Immune Checkpoint Blockades: The Underlying Mechanisms and Potential Strategies
by: Binghan Zhou, et al.
Published: (2021-06-01)

Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
by: Shengqing Stan Gu, et al.
Published: (2020-10-01)

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
by: Lin X, et al.
Published: (2021-03-01)

Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
by: Yanna Lei, et al.
Published: (2021-03-01)

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
by: Jun Gong, et al.
Published: (2018-10-01)

Prospects for combining immune checkpoint blockade with PARP inhibition
by: Anping Li, et al.
Published: (2019-09-01)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
by: Na Zhang, et al.
Published: (2020-11-01)

Implication of Microsatellite Instability in Chinese Cohort of Human Cancers
by: Cui M, et al.
Published: (2020-10-01)

Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
by: Qi Zhang, et al.
Published: (2020-10-01)

Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
by: Hao Wang, et al.
Published: (2019-06-01)

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer
by: Yang Y, et al.
Published: (2018-09-01)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
by: Jingjing Duan, et al.
Published: (2018-09-01)

Microsatellite instability: induction and prevention
by: Chang-LinWu, et al.
Published: (2017)

Oral cancer and Microsatellite instability
by: Xiao-ru Jian, et al.
Published: (2008)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01)

Rethinking immune checkpoint blockade: ‘Beyond the T cell’
by: Xiuting Liu, et al.
Published: (2021-01-01)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
by: Jan Christoph Banck, et al.
Published: (2021-03-01)

Acquired Resistance to Immune Checkpoint Blockade Therapies
by: Xianda Zhao, et al.
Published: (2020-05-01)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
by: Anja Wessely, et al.
Published: (2020-01-01)

Gastric Cancer in the Era of Immune Checkpoint Blockade
by: Lucía Figueroa-Protti, et al.
Published: (2019-01-01)

Smoldering myocarditis following immune checkpoint blockade
by: Timothy G. Norwood, et al.
Published: (2017-11-01)

Checkpoint Blockade in Cancer Immunotherapy: Squaring the Circle
by: Maria A.V. Marzolini, et al.
Published: (2015-03-01)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Brian J. Ahn, et al.
Published: (2013-11-01)

The role of neoantigen in immune checkpoint blockade therapy
by: Ming Yi, et al.
Published: (2018-11-01)

Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer
by: Li Zhang, et al.
Published: (2021-05-01)

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
by: Xiaolei Li, et al.
Published: (2018-02-01)